Mrs. Usha R Sood, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 18285 Ten Mile Rd, Suite 130, Roseville, MI 48066 Phone: 586-776-7546 Fax: 586-447-4910 |
Dr. Peter Jajou, D.O. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 18285 E 10 Mile Rd Ste 130, Roseville, MI 48066 Phone: 586-776-7546 |
News Archive
A team of scientists from the United States has recently revealed that about 25% of people with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop renal complications and that the viral spike protein can be detected in the urine samples of these patients. The study is currently available on the medRxiv* preprint server.
Type 2 diabetes greatly increases a person's risk of developing cardiovascular disease (CVD). A new study showing that cardiovascular risk factors such as elevated blood pressure and cholesterol levels differ significantly between men and women is published in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Researchers reported today that SolirisĀ® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.
GSK has become one of the first manufacturers to sign a unique agreement with the GAVI Alliance that has the potential to save millions of children from dying in the world's poorest countries. GSK will supply up to 300 million doses of its vaccine Synflorix, for invasive pneumococcal disease, to GAVI over a ten year period. Pneumococcal disease is a leading cause of death in children under the age of five in developing countries.
› Verified 3 days ago